Clinical Trials Browser

Phase 4 × Pamidronate × Clear all

NCT04549207 2025-11-28

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Phase 4 Active not recruiting

Breast Neoplasms

NCT00128297 2023-03-28

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

Phase 4 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01907880 2017-07-07

ER11-03

Phase 4 Completed

Breast Neoplasms, Pain

NCT02101164 2015-02-18

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Phase 4 Withdrawn

Bone Diseases

NCT02313727 2014-12-10

Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression

Phase 4 Unknown

Spondylitis, Ankylosing